期刊文献+

高容量血液滤过治疗脓毒症并发多器官功能障碍综合征RIFLE标准应用研究 被引量:9

RIFLE criteria for evaluation of high-volume hemofiltration in treatment of patients with sepsis multiple organ dysfunction syndrome
暂未订购
导出
摘要 目的探讨RIFLE标准衡量高容量血液滤过(HVHF)治疗脓毒症并发多器官功能障碍综合征(MODS)的治疗时机及其对预后的影响。方法回顾性分析成都军区总医院2006年1月至2010年12月行HVHF治疗的脓毒症并发MODS患者52例,采用RIFLE标准分A组(AKIⅠ期)、B组(AKIⅡ期)和C组(AKIⅢ期),比较各组的病死率、平均ICU住院时间、平均机械通气时间、平均连续血液滤过治疗时间,并将HVHF治疗前和治疗24 h后的APACHEⅡ评分、SOFA评分、血浆白介素(IL)-6、氧合指数、血肌酐(Scr)及平均动脉压(MAP)等指标。结果 (1)C组HVHF治疗前APACHEⅡ评分、SOFA评分、血浆IL-6及病死率均明显高于A、B组(P<0.01);(2)A、B组HVHF治疗前APACHEⅡ评分、SOFA评分及病死率比较差异无统计学意义(P>0.05),但B组HVHF治疗前IL-6及平均ICU住院时间、平均机械通气时间、平均连续血液滤过治疗时间明显高于或长于A组(P<0.01);(3)HVHF治疗24 h后血浆IL-6、氧合指数、Scr、MAP均明显改善,但C组IL-6仍高于A、B组(P<0.01),B组IL-6仍高于A组(P<0.01);A、B组HVHF治疗24 h后APACHEⅡ评分、SOFA评分显著降低(P<0.01),C组无变化(P>0.05)。结论 HVHF能有效辅助治疗脓毒症并发MODS;RIFLE标准及IL-6对判断预后有指导意义;早期(AKIⅠ期和Ⅱ期)行HVHF可明显改善脓毒症并发MODS的预后,而AKIⅠ期行HVHF的疗效更好。 Objective To explore the use of RIFLE criteria in evaluation oL therapeutic time of high-volume hemofihration (HVHF) in treatment of sepsis complicated with multiple organ dysfunction syndrome (MODS) and the effects of HVHF on prognosis. Methods Between January 2006 and September 2010,52 patients with sepsis and MODS undergoing HVHF in Chengdu PLA General Military Hospital were retrospectively analyzed and divided into group A ( AKI Ⅰ ) , group B ( AKI Ⅱ ) and group C ( AKI Ⅲ ) according to the RIFLE criteria. The mortality rate, mean ICU stay, mean mechanical ventilation time and the mean time of continuous HVHF treatment were compared among three groups. Moreover, indexes such as APACHE Ⅱ score, sequential organ failure assessment (SOFA) score, serum interleukin-6 ( IL-6 ), oxygenation index, plasma creatinine (Cr) and mean arterial pressure (MAP) before and at 24 h after HVHF treatment were also compared. Results ( 1 ) APACHE Ⅱ score, SOFA score, plasma IL-6 and the mortality rate in group C were significantly higher than those in groups A and B before HVHF treatment (P 〈0. 01 ) ;(2)There were no significant differences in APACHE Ⅱ score,SOFA score and the mortality rate in groups A group B before HVHF treatment (P 〉 0. 05 ) ,however, serum IL-6, mean ICU stay,mean mechanical ventilation time and the mean time of continuous HVHF treatment in group B were remarkably higher than those in group A (P 〈 0. 01 ) ;(3 )The plasma IL-6, oxygenate index, serum creatinine (Cr) and MAP were improved significantly at 24 h after HVHF treatment. Nevertheless, IL-6 in group C was still higher than those in groups A and B, and IL-6 in group B was higher than that in group A ( P 〈 0. 01 ) ; APACHE I score and SOFA score were decreased significantly in groups A and B (P 〈 0. 01 ), while no change was found in group C (P 〉 0. 05 ). Conclusion HVHF can be useful in assisting treatments for sepsis complicated with MODS ; RIFLE criteria and IL-6 may help prediction of prognosis ; Early HVHF treatment can remarkably improve the prognosis of sepsis complicated with MODS in stages AKI I and Ⅱ , while the efficacy of HVHF treatment can be better in AKI I stage.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第9期697-699,共3页 Chinese Journal of Practical Internal Medicine
基金 四川省卫生厅计划项目(编号100190) 四川省卫生厅资助项目(编号100095 100189)
关键词 高容量血液滤过 脓毒症 多器官功能障碍综合征 RIFLE标准 high-volume hemofiltration sepsis multiple organ dysfunction syndrome MODS RIFLE criteria
  • 相关文献

参考文献10

  • 1Romero CM, Downey P, Hem6ndez G. High volume hemofihration in septic shock[ J]. Med Intensiva,2010,34(5 ) :345 -352.
  • 2Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients[ J]. Crit Care Med,2006,34(7) :2016 -2017.
  • 3丁欢,马希刚,马玉杰,曹相原,杨晓军,王晓麒.脓毒症患者血浆抗凝血酶Ⅲ及D-二聚体与SOFA评分的相关性研究[J].中国实用内科杂志,2008,28(2):113-115. 被引量:16
  • 4李昂,王海曼,阴赪宏,王超,段美丽,张淑文.多器官功能障碍综合征患者急性呼吸窘迫综合征流行病学调查[J].中国实用内科杂志,2009,29(11):1036-1038. 被引量:6
  • 5Peng Z, Pai P, Hong-Bao L, et al. The impacts of continuous venovenous hemofihration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients [ J]. Cytokine, 2010,50(2) :186 - 191.
  • 6Patrick MH, Olivier JB, Willem B, et al. High-Volume Hemoflhration in Sepsis and SIRS:Current Concepts and Future Prospects [ J]. Blood Purif,2009,28 : 1 - 11.
  • 7Bell M, Liljestam E, Granath F, et al. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria [ J ]. Nephrol Dial Transplant,2005,20 ( 2 ) :354 - 360.
  • 8Lin WC, Lin CF, Chen CL, et al. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators[ J]. Exp Biol Med ( Maywood), 2010,235 (1) :57 -65.
  • 9De1 Sorbo L, Slutsky AS. Acute respiratory distress syndrome and multiple organ failure [ J ]. Curr Opin Cfit Care, 2011,17 ( 1 ) : 1 - 6.
  • 10Payen D, Mateo J, Cavaillon JM, et al. Impact of continuous veno- venous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial [ J ]. Crit Care Med, 2009,37(3) :803 -810.

二级参考文献18

  • 1王超,苏强,张淑文,阴赪宏,王红,王宝恩.多器官功能障碍综合征病情严重度评分及预后评估系统在预测住院病死率中的作用[J].中华创伤杂志,2006,22(8):574-578. 被引量:19
  • 2中华医学会重症医学分会,马晓春,王辰,方强,刘大为,邱海波,秦英智,席修明,黎毅敏.急性肺损伤/急性呼吸窘迫综合征诊断和治疗指南(2006)[J].中国危重病急救医学,2006,18(12):706-710. 被引量:659
  • 3Linko R, Okkonen M, Pettila V, et al. Acute respiratory failure in intensive care units. FINNALI:a prospective cohort study [ J ]. Intensive Care Med (SpringerLink online) ,2009.
  • 4Brun-Buisson C, MineUi C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study [ J ]. Intensive Care Med, 2004,30 (1) :51 -61.
  • 5Marshall JC, Cook D J, Christou NV, et al. Multiple organ dysfunction score : a reliable descriptor of acomplex clinical outcome [ J ]. Crit Care Med,1995,23 (10) :1638 - 1652.
  • 6LevyM M,Fink M P,Marshall J C,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference [ J ]. Grit Care Med,2003,31 ( 4 ) : 1250 - 1256.
  • 7Bone RC, Balk RA, Cerra FB, et al. The ACCP/SCCM consensus conference committee:definitions for sepsis and organ-failure and guideline for the use of innovative therapies in sepsis [ J ]. Chest, 1992,101 (6) :1644 - 1655.
  • 8Philtip D, Mitchell ML, Jean MC, et al. Surviving Sepsis Campaign:International guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Intensive Care Med,2008,34:17 - 460.
  • 9Kinasewitz GT, Yan SB, Basson B,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ J ]. Crit Care, 2004,8 ( 2 ) : R82 - R90.
  • 10Arts DG,de Keizer NF,Vroom MB,et al. Reliability and accuracy of sequential organ failure assessment ( SOFA ) scoring [ J ]. Crit Care Med,2005,33 ( 9 ) : 1988 - 1993.

共引文献20

同被引文献88

引证文献9

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部